Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Beta-ketothiolase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Beta-ketothiolase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals,.
Latest Hotspot
10 min read
Multiple carboxylase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Multiple carboxylase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Pyridoxal phosphate-responsive epilepsy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Pyridoxal phosphate-responsive epilepsy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Pyridoxine-dependent epilepsy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Pyridoxine-dependent epilepsy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Sulfite oxidase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Sulfite oxidase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Molybdenum cofactor deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Molybdenum cofactor deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
N-acetylglutamate synthase deficiency Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 N-acetylglutamate synthase deficiency strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Hyperinsulinism-hyperammonemia syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Hyperinsulinism-hyperammonemia syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Citrullinemia type 1 Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Citrullinemia type 1 strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Hereditary orotic aciduria Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Hereditary orotic aciduria strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Lesch-Nyhan syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Lesch-Nyhan syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.